Nanoparticle-induced cell culture models for degenerative protein aggregation diseases Nanoparticles and aggregation diseases

Inhalation Toxicology

Volumn 21, Issue SUPPL. 1, 2009, Pages 110-114

  Min, Chen ^a   Anna Von, Mikecz ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; NANOPARTICLE; POLYGLUTAMINE;

ARTICLE; CELL CULTURE; CELL NUCLEUS INCLUSION BODY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION;

CELL LINE; HUMANS; INTRANUCLEAR INCLUSION BODIES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEIN FOLDING; RISK ASSESSMENT; SILICON DIOXIDE; TIME FACTORS; TOXICITY TESTS; UBIQUITINATION;

EID: 70350671470     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370902942558     Document Type: Article

References (15)

1. Boland, S., A., Baeza-Squiban, T. Fournier, O. Houcine, M.C. Gendron, M. Chevrier, G. Jouvenot, A. Coste, M. Aubier, and F. Marano. 1999. Diesel exhaust particles are taken up by human airway epithelial cells in vitro and alter cytokine production. Am. J. Physiol. 276, L604-613.
2. Chen, M., and A. von Mikecz. 2005. Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp. Cell Res. 305, 51-62.
3. Chen, M., L. Singer, A. Scharf, and A. von Mikecz. 2008. Nuclear polyglutaminecontaining protein aggregates as active proteolytic centers. J. Cell Biol. 180, 697-704.
4. Goldberg, A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899.
5. Kirkwood, T.B. 2005. Understanding the odd science of aging. Cell 120, 437-447.
6. Linse, S., C. Cabaleiro-Lago, W.-F., Xue, I. Lynch, S. Lindman, E. Thulin, S.E. Radford, and K.A. Dawson. 2007. Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. USA 104, 8691-8696.
7. Misteli, T. 2007. Beyond the sequence: Cellular organization of genome function. Cell 128, 787-800.
8. Mühlfeld, C., B. Rothen-Rutishauser, D. Vanhecke, F. Blank, P. Gehr, and M. Ochs. 2007. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol. 4, 11.
9. Oberdörster, G., E. Oberdörster,and J. Oberdörster. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823-839.
10. Oberdörster, G., Z. Sharp, V. Atudorei, A. Elder, R. Gelein, W. Kreyling, and C. Cox. 2004. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol. 16, 437-445.
11. Slow, E.J., R.K. Graham, and M.R. Hayden. 2006. To be or not to be toxic: Aggregations in Huntington and Alzheimer disease. Trends Genet. 22, 408-411.
12. Takenaka, S., E. Karg, W.M. Möller, C. Roth, A. Ziesenis, U. Heinzmann, P. Schramel, and J. Heyder. 2000. A morphologic study on the fate of ultrafine silver particles: Distribution patterns of phagocytosed metallic silver in vitro and in vivo. Inhal. Toxicol. 12, 291-300.
13. Vernace, V.A., T. Schmidt-Glenewinkel, and M.E. Figueiredo-Pereira. 2007. Aging and regulated protein degradation: who has the UPPer hand? Aging Cell 6, 599-606.
14. Von Mikecz A. 2006. The nuclear ubiquitin-proteasome system. J. Cell Sci. 119, 1977-1984.
15. Weidtkamp-Peters, S., K. Weisshart, L. Schmiedeberg, and P. Hemmerich. 2008. Fluorescence correlation spectroscopy to assess the mobility of nuclear proteins. Methods Mol Biol. 464, 321-341.